SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

STRIDES PHARMA SCIENCE

BSE: 532531 29 Sep 2025
Healthcare
₹ 887.45
STRIDES PHARMA SCIENCE LIMITED specializes in Pharmaceuticals within the Healthcare sector.

STRIDES PHARMA SCIENCE - Share Price & Details

Market Cap
₹7,517
High /Low
972.0 / 513.0
Stock P/E
20.1
Book Value
₹277.0
Dividend Yield
0.49
ROCE
14.7
ROE
₹151.0
Face Value
10.0
PEG Ratio
0.13
EVEBITDA
₹10.4
Debt
1,880
CMP / FCF
19.8
Debt to equity
₹0.74
NP Ann
3,598
High price all time
972.0
Piotroski score
₹7.0
Graham Number
480.0
No. Eq. Shares
9.22
Net CF
₹-48.5
Net profit
354
Price to book value
2.95
Interest Coverage
₹3.1
Low price all time
26.0
Industry PE
33.0
Reserves
₹2,460
Free Cash Flow
₹510

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
24 Oct 2024 Sharekhan Buy ₹1,534.65 ₹1,874 19.9% moneycontrol View
30 Jan 2024 Sharekhan ₹700.1 ₹800 -49.8% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
STRIDES PHARMA SCIENCE LIMITED5003.74133.474986.161.457,51720.1
Aarti Pharmalabs Limited3769.06512.213753.110746928.0
MARKSANS PHARMA LTD.3217.44480.563197.341.06744921.3

Peer Comparison Chart


About STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE LIMITED, with Security Code 532531, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Strides Pharma Science (NSEI:STAR) - Stock Analysis

(18 Sep 2025)
Research Strides Pharma Science's (NSEI:STAR) fundamentals, past performance, valuation, dividends and more.
Read more →

Strides inks strategic product development partnership with Kenox

(16 Sep 2025)
15 September 2025. More on this story... India and China vie for leadership in biotech and pharma R&D. Pharmaceutical.
Read more →

Strides Pharma Science Singapore arm, Kenox Pharma partner to develop multiple nasal spray products for...

(10 Sep 2025)
Bangalore: Strides Pharma Science Ltd has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte.
Read more →

Strides Pharma, Kenox Team Up for US Nasal Spray Market; Shares Trading Flat

(10 Sep 2025)
Shares of Strides Pharma Science Ltd traded flat on 9th September after touching a day's high of Rs 894. This occurred even as the company...
Read more →

Kenox Enters into Strategic Product Development Partnership with Strides

(10 Sep 2025)
PRNewswire/ -- Strides Pharma Science Ltd today announced that its step-down, wholly owned subsidiary, Strides Pharma Global Pte.
Read more →

Strides Pharma partners with Kenox with eye on US nasal spray market

(09 Sep 2025)
Drug firm Strides Pharma Science Ltd on Monday (September 8) announced that its wholly-owned subsidiary, Strides Pharma Global Pte.
Read more →